GPX4 is a key ferroptosis regulator orchestrating T cells and CAR-T-cells sensitivity to ferroptosis

Marta Kłopotowska1, Iwona Baranowska1, Szymon Hajduk1,2

  • 1Department of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences, 5 Adolfa Pawinskiego St., 02-106, Warsaw, Poland.

Insights

T-cell stimulation induces ferroptosis, a cell death pathway, by disrupting iron and redox balance. This vulnerability, particularly in CD8+ T cells, can limit CAR-T cell therapy efficacy, suggesting strategies to enhance T-cell resistance to ferroptosis.

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Therapy

Background:

  • Ferroptosis, an iron-dependent cell death, is a promising strategy against tumor resistance and for enhancing immunotherapy.
  • Tumor cell ferroptosis susceptibility is well-studied, but immune cell vulnerability to iron dysregulation and lipid peroxidation is less understood.

Purpose of the Study:

  • To investigate the impact of T-cell stimulation on iron homeostasis, redox balance, and ferroptosis susceptibility in T cells.
  • To identify regulators of T-cell ferroptosis and assess the implications for CAR-T cell therapy.

Main Methods:

  • Analysis of iron and redox homeostasis, reactive oxygen species, labile iron, and lipid peroxidation in stimulated T cells.
  • Assessment of ferroptosis-suppressive proteins, including GPX4, and their role in T-cell ferroptosis.
  • Evaluation of ferroptosis sensitivity across different T-cell subsets (CD4+, CD8+, naïve, CM, EM, TEMRA) and its effect on CAR-T cell anti-tumor functions in vitro and in vivo.

Main Results:

  • T-cell stimulation increases reactive oxygen species and labile iron, promoting lipid peroxidation and T-cell ferroptosis.
  • GPX4 was identified as a key regulator of T/CAR-T cell ferroptosis sensitivity; GPX4 inhibition impaired CAR-T cell anti-tumor functions.
  • CD8+ effector memory (EM) and terminally differentiated effector memory (TEMRA) cells showed the highest ferroptosis sensitivity.
  • Ferroptosis limited CAR-T cell efficacy, while its inhibition improved therapeutic effects in vitro and in vivo.

Conclusions:

  • T-cell stimulation induces ferroptosis, posing a vulnerability for CAR-T cell therapy.
  • Targeting GPX4 affects CAR-T cell function, highlighting its role in ferroptosis regulation.
  • Therapeutic strategies should aim to selectively induce tumor cell ferroptosis while preserving cytotoxic cell function, potentially by promoting less differentiated CAR-T cells resistant to ferroptosis.